MARLBOROUGH, Mass., June 12, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, is pleased to announce that it has won ChannelVision's 2024 Visionary Spotlight Award (VSA) for Cybersecurity (Business Technology) for its market-leading Corero SmartWall ONE™ DDoS protection solution. The annual VSA competition highlights both channel and service provider innovation in communications, honoring outstanding products, services a ...

Cohen & Steers, Inc. (CNS) reported preliminary assets under management (AUM) of $80.5 billion as of May 31, 2024. This reflected growth of 4.3% from the prior month's level. The increase was mainly attributable to a market appreciation of $3.6 billion. This was partly offset by net outflows of $93 million and distributions of $150 million. Cohen & Steers recorded total institutional accounts of $32.1 billion at the end of May 2024, jumping 4.8% from the April 2024-end. Of the total institutional accounts, ...

NEW YORK, June 10, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $80.5 billion as of May 31, 2024, an increase of $3.3 billion from assets under management of $77.2 billion at April 30, 2024. The increase was due to market appreciation of $3.6 billion, partially offset by distributions of $150 million and net outflows of $93 million. Assets Under Management (unaudited) ($ in millions) AUM Net Market AUM By investment vehicle: 4/30/2024FlowsApprec ...

koto_feja/E+ via Getty Images ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company specializing in developing treatments for central nervous system [CNS] conditions. The company has two successful FDA-approved commercial franchises, Nuplazid (pimavanserin), approved in 2016 for Parkinson’s disease psychosis, and Daybue (trofinetide), approved in March 2023 for Rett syndrome. Despite a setback with a failed clinical trial for a new indication for Nuplazid as a treatment for schizophrenia, ...

VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice Additive effects were observed for VTX3232 in combination with the GLP-1 receptor agonist semaglutide across key endpoints compared to semaglutide or VTX3232 alone SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a br ...

NEW YORK, May 15, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today additional pending changes to its Realty Majors Indexes, effective as of the close of business on May 17, 2024. LondonMetric Property Plc replaces LXI REIT Plc in the Cohen & Steers Global Realty Majors Portfolio Index (GRM) and Cohen & Steers International Realty Majors Portfolio Index (IRP). The changes result from the former's acquisition of the latter. Additional previously announced changes to the indexes are listed ...

NEW YORK, May 13, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today a change to its Realty Majors Portfolio Index (RMP) capitalization policy. Currently, individual index constituent capitalization weights are limited to a maximum of 8%. Effective as of close of business on May 17, 2024, constituent weightings will now be subject to an additional adjustment if the sum of the constituents that individually have a weight greater than 4.5% exceeds 45% of the total index. If the new rule is ...

Cohen & Steers, Inc. (CNS) reported preliminary assets under management (AUM) of $77.2 billion as of Apr 30, 2024. This reflected a decline of 4.9% from the prior month's level. The decrease was due to market depreciation of $3.9 billion, net outflows of $74 million and distributions of $151 million. Cohen & Steers recorded total institutional accounts of $30.6 billion at the end of April 2024, falling 5.5% from the March 2024-end level. Of the total institutional accounts, advisory accounts were $17.4 bill ...

NEW YORK, May 8, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $77.2 billion as of April 30, 2024, a decrease of $4.1 billion from assets under management of $81.2 billion at March 31, 2024. The decrease was due to market depreciation of $3.9 billion, net outflows of $74 million and distributions of $151 million. Assets Under Management (unaudited) ($ in millions) AUM Net Market AUM By investment vehicle: 3/31/2024FlowsDepreciationDistributions4/ ...

________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-32236 ________________ COHEN & STEERS, INC. (Exact Name of Registrant ...